CSS
ITOS

Cubist Systematic Strategies’s iTeos Therapeutics ITOS Stock Holding History

Cubist Systematic Strategies’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-112,092
Closed -$669K – 3250
2025
Q1 		$669K Buy
112,092
+49,914
+80% +$366K ﹤0.01% 2031
2024
Q4 		$478K Sell
62,178
-70,186
-53% -$603K ﹤0.01% 2201
2024
Q3 		$1.35M Buy
+132,364
New +$2.02M 0.01% 1647
2024
Q2 		– Sell
-103,981
Closed -$1.42M – 3485
2024
Q1 		$1.42M Sell
103,981
-30,021
-22% -$327K 0.01% 1891
2023
Q4 		$1.47M Buy
134,002
+120,925
+925% +$1.2M 0.01% 1758
2023
Q3 		$143K Buy
+13,077
New +$167K ﹤0.01% 2870
2023
Q2 		– Sell
-46,448
Closed -$632K – 3906
2023
Q1 		$632K Buy
+46,448
New +$832K ﹤0.01% 2514
2022
Q3 		– Sell
-22,127
Closed -$456K – 4573
2022
Q2 		$456K Sell
22,127
-4,208
-16% -$99.9K ﹤0.01% 3123
2022
Q1 		$847K Sell
26,335
-27,172
-51% -$987K 0.01% 2167
2021
Q4 		$2.49M Buy
53,507
+42,323
+378% +$1.41M 0.02% 1185
2021
Q3 		$302K Sell
11,184
-14,031
-56% -$367K ﹤0.01% 2350
2021
Q2 		$647K Buy
+25,215
New +$601K 0.01% 1838

Other funds holding ITOS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's ITOS Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 112,092 shares — an estimated $669K sold.

Cubist Systematic Strategies first reported a position in ITOS in Q2 2021 and held it in 12 quarters. The position peaked at $2.49M in Q4 2021. 136 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 112,092 iTeos Therapeutics shares in Q2 2025, an estimated $669K.
  • Cubist Systematic Strategies first reported a position in iTeos Therapeutics in Q2 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's iTeos Therapeutics position peaked at $2.49M in Q4 2021.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.